Correlation Between Sana Biotechnology and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Editas Medicine, you can compare the effects of market volatilities on Sana Biotechnology and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Editas Medicine.
Diversification Opportunities for Sana Biotechnology and Editas Medicine
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Sana and Editas is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Editas Medicine go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Editas Medicine
Given the investment horizon of 90 days Sana Biotechnology is expected to generate 1.25 times more return on investment than Editas Medicine. However, Sana Biotechnology is 1.25 times more volatile than Editas Medicine. It trades about 0.01 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.04 per unit of risk. If you would invest 431.00 in Sana Biotechnology on August 27, 2024 and sell it today you would lose (170.00) from holding Sana Biotechnology or give up 39.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sana Biotechnology vs. Editas Medicine
Performance |
| Timeline |
| Sana Biotechnology |
| Editas Medicine |
Sana Biotechnology and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sana Biotechnology and Editas Medicine
The main advantage of trading using opposite Sana Biotechnology and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |